Therapeutic mi R21 Silencing Ameliorates Diabetic Kidney Disease
Therapeutic mi. R-21 Silencing Ameliorates Diabetic Kidney Disease in Mice Malte Kölling, Tamas Kaucsar, Celina Schauerte, Anika Hübner, Angela Dettling, Joon-Keun Park, Martin Busch, Xaver Wulff, Matthias Meier, Kristian Scherf, Nóra Bukosza, Gábor Szénási, Mária Godó, Amit Sharma, Michael Heuser, Peter Hamar, Claudia Bang, Hermann Haller, Thomas Thum, Johan M. Lorenzen Molecular Therapy Volume 25 Issue 1 Pages 165 -180 (January 2017) DOI: 10. 1016/j. ymthe. 2016. 08. 001 Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions
Figure 1 Molecular Therapy 2017 25165 -180 DOI: (10. 1016/j. ymthe. 2016. 08. 001) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions
Figure 2 Molecular Therapy 2017 25165 -180 DOI: (10. 1016/j. ymthe. 2016. 08. 001) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions
Figure 3 Molecular Therapy 2017 25165 -180 DOI: (10. 1016/j. ymthe. 2016. 08. 001) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions
Figure 4 Molecular Therapy 2017 25165 -180 DOI: (10. 1016/j. ymthe. 2016. 08. 001) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions
Figure 5 Molecular Therapy 2017 25165 -180 DOI: (10. 1016/j. ymthe. 2016. 08. 001) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions
Figure 6 Molecular Therapy 2017 25165 -180 DOI: (10. 1016/j. ymthe. 2016. 08. 001) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions
Figure 7 Molecular Therapy 2017 25165 -180 DOI: (10. 1016/j. ymthe. 2016. 08. 001) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions
- Slides: 8
